Involvement of DPP9 in gene fusions in serous ovarian carcinoma

BMC Cancer

Table 1 Clinical information

Sample	Patient	Age	Dx	Stadium	Karyotype: chr19	RNA-seq	Neo chemo
1	I	66	HGSC	IIIC	No der(19)^b
2	II	47	HGSC	IIIB	der(19)	V
3	IIIa	54	HGSC	IIIC	No der(19)^b
4	IIIb	54	HGSC	IIIC	der(19)	V
5	IVa	61	HGSC	IIIC	Culture failure^b
6	IVb	61	HGSC	IIIC	der(19)	V
7	V	52	HGSC	IIIC	der(19)	V
8	VI	50	HGSC	IV	der(19)	V
9	VII	66	HGSC	IV	der(19)	V
10	VIII	59	HGSC	IV	der(19)	V	yes
11	IX	56	HGSC	IIIC	der(19)	V
12	X	51	UC	IIC	der(19)	V
13	XI	74	HGSC	IIIC	der(19)	V	yes
14	XII	57	HGSC	IIIC	46,XX^b
15	XIIIa	64	HGSC	IIC	der(19)	V
16	XIIIb	64	HGSC	IIC	46,XX^b
17	XIV	63	HGSC	IIIC	der(19)	V
18	XV	56	SC^a	IIIC	der(19)		yes
19	XVI	77	HGSC	IIIC	der(19)	V

Dx diagnosis, HGSC high-grade serous carcinoma, Neo chemo neoadjuvant chemotherapy, UC undifferentiated carcinoma
^aSC = serous carcinoma, cannot be graded due to chemo
^bbilateral tumor has der(19) in the karyotype

ISSN: 1471-2407